Cogent Biosciences, Inc. (COGT) Net income 2017–2025
Cogent Biosciences, Inc. (COGT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$328.9MFY2025 · since FY2017: -$25.5M → -$328.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$328.9M | -28.6% |
| FY2024 | -$255.9M | -33.0% |
| FY2023 | -$192.4M | -37.2% |
| FY2022 | -$140.2M | -94.0% |
| FY2021 | -$72.3M | +3.4% |
| FY2020 | -$74.8M | -135.0% |
| FY2019 | -$31.8M | +7.8% |
| FY2018 | -$34.5M | -35.5% |
| FY2017 | -$25.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice